Showing results (91-100 of 212) with videos related to
Sort By:
Pageof 22
Current Drug Metabolism|May 17, 2007
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cellsPaola Secchiero, Carlotta Zerbinati, Maria Grazia di Iasio, et al.Journal of Immunology Research|April 18, 2014
Modulation of circulating cytokine-chemokine profile in patients affected by chronic venous insufficiency undergoing surgical hemodynamic correctionVeronica Tisato, Giorgio Zauli, Sergio Gianesini, et al.Acta Diabetologica|August 9, 2013
The levels of circulating TRAIL at the onset of type 1 diabetes are markedly decreased in patients with ketoacidosis and with the highest insulin requirementGianluca Tornese, Dario Iafusco, Lorenzo Monasta, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 27, 2021
Role of vitamin D in the pathogenesis of atheromatosisErika Rimondi, Annalisa Marcuzzi, Fabio Casciano, et al.Molecules (Basel, Switzerland)|November 13, 2021
Anticancer Activity of Aqueous Extracts from Asparagus officinalis L. Byproduct on Breast Cancer CellsArianna Romani, Fabio Casciano, Claudia Stevanin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2011
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cellsGiorgio Zauli, Rebecca Voltan, Maria Grazia di Iasio, et al.Blood|September 20, 2002
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathwayPaola Secchiero, Arianna Gonelli, Prisco Mirandola, et al.Journal of Leukocyte Biology|July 30, 2003
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cellsPaola Secchiero, Daniela Milani, Arianna Gonelli, et al.Journal of Cellular Physiology|June 11, 2011
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cellsFederica Corallini, Claudio Celeghini, Erika Rimondi, et al.Neoplasia (New York, N.Y.)|July 17, 2004
Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligandPaola Secchiero, Arianna Gonelli, Edvige Carnevale, et al.Pageof 22